BetterLife Pharma Inc. (CSE: BETR)

Market Cap	15.32M
Revenue (ttm)	n/a
Net Income (ttm)	-4.88M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,500
Open	0.105
Previous Close	0.115
Day's Range	0.105 - 0.120
52-Week Range	0.050 - 0.195
Beta	1.42
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 26, 2024

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benz...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BETR